Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
Q4 2024 vs. Q3 2024
How the institutions holding Cidara Therapeutics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 27 | 40 | +13 |
| Shares | 3.31M | 6.87M | +3.57M (+107.8%) |
| Value | $35.6M | $183.6M | +$148.1M (+416.3%) |
New holders (17)
Institutions that held Cidara Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| TCG Crossover Management, LLC | 1,005,901 | $26.1M | 2.55% |
| VR Adviser, LLC | 765,723 | $20.6M | 1.41% |
| Vivo Capital, LLC | 670,600 | $18.0M | 2.02% |
| Acuta Capital Partners, LLC | 54,473 | $1.46M | 1.47% |
| Ikarian Capital, LLC | 53,940 | $1.45M | 0.41% |
| StemPoint Capital LP | 47,642 | $1.28M | 0.32% |
| Susquehanna International Group, LLP | 42,623 | $1.15M | 0.00% |
| ADAR1 Capital Management, LLC | 24,938 | $670.3K | 0.14% |
| Boothbay Fund Management, LLC | 15,601 | $419.4K | 0.01% |
| Goldman Sachs Group Inc | 13,870 | $372.8K | 0.00% |
| Jane Street Group, LLC | 12,714 | $341.8K | 0.00% |
| Omers Administration Corp | 12,600 | $338.7K | 0.00% |
| Citigroup Inc | 7,584 | $203.9K | 0.00% |
| Point72 Asset Management, L.P. | 6,148 | $165.2K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 2,085 | $56.0K | 0.01% |
| Point72 (DIFC) Ltd | 198 | $5.33K | 0.00% |
| SBI Securities Co., Ltd. | 20 | $538 | 0.00% |
Sold out (4)
Institutions that held Cidara Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Monashee Investment Management LLC | 369,099 | $3.97M |
| Tower Research Capital LLC (TRC) | 1,115 | $12.0K |
| Russell Investments Group, Ltd. | 855 | $9.19K |
| Pacifica Partners Inc. | 400 | $4.30K |